Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Rose

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Anticancer Research|May 1, 1992
Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551)W T Bradner, J J Catino, B H Long, et al.
Journal of Biomechanics|June 26, 2012
Identification of scapular kinematics using surface mapping: a validation studyJ M Mattson, S A Russo, W C Rose, et al.
Journal of the National Cancer Institute|July 1, 1975
Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR miceW C Rose, A A Rimm, E C Saltzstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR miceM M Bortin, R L Truitt, W C Rose, et al.
Transplantation|April 1, 1976
Transplantation of hematopoietic and lymphoid cells in miceM M Bortin, A A Rimm, W C Rose, et al.
Experimental Hematology|March 1, 1976
Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxinW C Rose, G E Rodey, A A Rimm, et al.
The Journal of Antibiotics|December 1, 1995
Production and isolation of two novel esperamicins in a chemically defined mediumK S Lam, J A Veitch, J Golik, et al.
Journal of Medicinal Chemistry|July 1, 1985
Reductive amination of 3-ketoanguidin and antitumor activity of the productsT Kaneko, H Wong, H G Howell, et al.
Investigational New Drugs|February 1, 1990
Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agentJ E Schurig, W C Rose, H Kamei, et al.
The Journal of Antibiotics|September 1, 1989
Antitumor activity of chrysomycins M and VJ A Matson, W C Rose, J A Bush, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Anticancer Research|May 1, 1992
Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551)W T Bradner, J J Catino, B H Long, et al.
Journal of Biomechanics|June 26, 2012
Identification of scapular kinematics using surface mapping: a validation studyJ M Mattson, S A Russo, W C Rose, et al.
Journal of the National Cancer Institute|July 1, 1975
Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR miceW C Rose, A A Rimm, E C Saltzstein, et al.
Advances in Experimental Medicine and Biology|January 1, 1976
Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR miceM M Bortin, R L Truitt, W C Rose, et al.
Transplantation|April 1, 1976
Transplantation of hematopoietic and lymphoid cells in miceM M Bortin, A A Rimm, W C Rose, et al.
Experimental Hematology|March 1, 1976
Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxinW C Rose, G E Rodey, A A Rimm, et al.
The Journal of Antibiotics|December 1, 1995
Production and isolation of two novel esperamicins in a chemically defined mediumK S Lam, J A Veitch, J Golik, et al.
Journal of Medicinal Chemistry|July 1, 1985
Reductive amination of 3-ketoanguidin and antitumor activity of the productsT Kaneko, H Wong, H G Howell, et al.
Investigational New Drugs|February 1, 1990
Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agentJ E Schurig, W C Rose, H Kamei, et al.
The Journal of Antibiotics|September 1, 1989
Antitumor activity of chrysomycins M and VJ A Matson, W C Rose, J A Bush, et al.
Pageof 10